Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study-Reference-Cited by-同舟云学术

Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study

Published:2023-06 Issue: Volume:Volume 10 Page:1009-1017
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Li Han,Guo Lu,Su Ke,Li Changlun,Jiang Yi,Wang Pan^ORCID,Chen Jiali,Wu Zhenying,Xu Ke,Gu Tao,Zeng Hao,He Kun,Chi Hao^ORCID,Zhao Wenxi,Han Lei,Han Yunwei^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference24 articles.

1. Epidemiology and Management of Hepatocellular Carcinoma

2. Hepatocellular carcinoma

3. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

4. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

5. Hepatocellular carcinoma

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study;Annals of Hepatology;2024-09

2. Postoperative adjuvant immunotherapy and molecular targeted therapy for patients of hepatocellular carcinoma with portal vein tumor thrombus after hepatectomy: a propensity score matching study;Frontiers in Surgery;2024-08-07

3. Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights;Frontiers in Immunology;2024-07-16

4. Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma;Frontiers in Pharmacology;2024-06-20

5. Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors;Journal of Hepatocellular Carcinoma;2024-04